The Home Depot, Inc.

TIKR's mid-case model projects Home Depot's EBITDA reaching $8 billion by July 2027, up 7% year over year, as the housing market gradually recovers. Analysts at Morgan Stanley, TD Cowen, and Telsey Advisory Group have issued buy or outperform ratings, anticipating that pent-up remodeling demand will unlock as mortgage rates ease.

High mortgage rates and the mortgage lock-in effect have kept housing turnover at historically low levels, suppressing demand for large discretionary renovations. A recent analyst downgrade noted that the housing market remains constrained, rate risk is elevated, and near-term growth could stay muted, with Home Depot's own guidance reflecting only a flat to modestly positive home-improvement market in 2026.

With EBITDA margin bottoming at 13% in the January 2026 quarter and consensus estimates pointing to a recovery toward 17% by July 2027, some analysts argue that the Street's mean target of $370 significantly undervalues the operating leverage embedded in the business. TIKR's model yields a $524 price target by 2031, representing a 10% annualized return.

Despite beating sales estimates, margins continue to slide, raising concerns about whether the recovery narrative is credible. The mean analyst price target was trimmed from $408 in early May 2026 to $370 following earnings, reflecting growing skepticism that Home Depot can sustain meaningful margin expansion in a soft remodeling environment.

With a consensus analyst price target of approximately $388 and roughly 78% of covering analysts rating the stock a buy or strong buy, the market sees meaningful upside from current levels. Home Depot's reaffirmed FY2026 guidance of 2.5% to 4.5% total sales growth and its operating margin guidance of 12.4% to 12.6% provide investors a degree of earnings visibility.

Several Seeking Alpha analyses flag that Home Depot appears overvalued relative to its near-term earnings growth prospects, with one piece explicitly warning the stock is 'unlikely to go anywhere anytime soon' and another noting 'no growth catalysts in the near future.' The wide analyst price target range — from $310 to $430 — reflects deep disagreement over whether current multiples are justified.